PositiveID Corporation Files Patent for Glucose-Sensing System to be Used in Its GlucoChip Microchip for Patients With Diabetes

PositiveID Corporation

announced today it has filed a patent with the U.S. Patent & Trademark Office for its recently completed stable and reproducible, closed-cycle continuous glucose-sensing system that is the mission-critical component of its GlucoChip™ glucose-sensing microchip for patients with diabetes. PositiveID now has five patents and patents pending surrounding the development of GlucoChip.